Cheng, Guangcun <br/><br/>
Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.  [electronic resource] 

 -  Molecular cancer  04 2016 
 - 30 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-4598 
<br/><br/><label>Standard No.: </label>10.1186/s12943-016-0515-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--pharmacology<br/>Cell Cycle Checkpoints--genetics<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Computational Biology--methods<br/>Cyclin D1--genetics<br/>DNA Methylation<br/>Databases, Genetic<br/>Disease Models, Animal<br/>Female<br/>Gene Expression<br/>Gene Expression Regulation, Neoplastic<br/>Gene Silencing<br/>Humans<br/>Kaplan-Meier Estimate<br/>Mice<br/>Prognosis<br/>Promoter Regions, Genetic<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Signal Transduction<br/>Tissue Inhibitor of Metalloproteinase-1--antagonists & inhibitors<br/>Triple Negative Breast Neoplasms--genetics<br/>Tumor Burden--drug effects<br/>Xenograft Model Antitumor Assays